Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asia
Biotech
Hansoh, Chugai ink separate and lucrative licensing agreements
A pair of licensing deals has emerged from Hansoh Pharma and Rani Therapeutics that together represent billions of dollars in potential payouts.
Fraiser Kansteiner
Oct 17, 2025 11:04am
Nasdaq plans 24-hour trading for US
Mar 7, 2025 12:32pm
CRO and clinical trial markets set for growth by 2030: reports
Dec 4, 2024 3:15pm
Health tech firm aims to expand trial access in Asia
Dec 4, 2024 9:00am
Lokavant snares $8M investment to expand its presence in Asia
Oct 5, 2023 9:20am
Inventiva, Kezar sell Asian rights to NASH and autoimmune assets
Sep 21, 2023 9:00am
